logo

KOVAI vs NOVARTIND: Stock Comparison

KOVAI MEDICAL CENTER & HO vs NOVARTIS INDIAUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

KOVAI MEDICAL CENTER & HO is the larger company by market capitalisation. KOVAI MEDICAL CENTER & HO shows a lower P/E, a higher ROE and a higher dividend yield, while NOVARTIS INDIA shows faster revenue growth, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KOVAI leads 7; NOVARTIND leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KOVAINOVARTIND

Valuation lens

What price are you paying?

Market CapContext only
₹6,426 Cr
₹4,753 Cr
P/E RatioKOVAI has the lower reading
25.07x ✓
48.61x
P/B RatioKOVAI has the lower reading
4.87x ✓
5.81x
EPSKOVAI has the higher reading
₹63.14 ✓
₹13.05
Book ValueContext only
₹1,205.66
₹331.23
Dividend YieldKOVAI has the higher reading
0.26% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
KOVAI is the larger company
₹6,426 Cr vs ₹4,753 Cr
P/E Ratio
KOVAI has a lower P/E
25.07x vs 48.61x
P/B Ratio
KOVAI has a lower P/B
4.87x vs 5.81x
EPS
KOVAI has higher earnings per share
₹63.14 vs ₹13.05
Dividend Yield
KOVAI has a higher dividend yield
0.26% vs 0%
Revenue Growth (TTM YoY)
NOVARTIND has faster revenue growth
8% vs 0%
EPS Growth (TTM YoY)
KOVAI has faster EPS growth
0% vs -13.8%
Qtr Sales Growth
NOVARTIND has stronger quarterly sales growth
14.64% vs 4.28%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKOVAINOVARTIND
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricKOVAINOVARTIND
Live Price₹5,875₹1,921.6
Day Change-1.64%1.26%
Volume4,31912,000
52-Week High₹6,444₹2,588.8
52-Week Low₹5,275.5₹950
Distance from 52W High-8.83%-25.77%

Valuation

MetricKOVAINOVARTIND
Market Cap₹6,426 Cr₹4,753 Cr
P/E Ratio25.07x48.61x
P/B Ratio4.87x5.81x
EPS₹63.14₹13.05
Book Value₹1,205.66₹331.23
Dividend Yield0.26%0%

Growth

MetricKOVAINOVARTIND
Revenue Growth (TTM YoY)0%8%
EPS Growth (TTM YoY)0%-13.8%
Qtr Sales Growth4.28%14.64%
Qtr Profit Growth9.05%27.56%

Profitability & Leverage

MetricKOVAINOVARTIND
ROE18.25%11.39%
ROCE15.59%14.33%
Net Margin15.42%26.3%
Operating Margin22.55%36.95%
Debt to Equity0.28x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKOVAINOVARTIND
Promoter Holding55.81%0%
FII Holding1.25%▲ 0.05 pp0.16%▼ 0.01 pp
DII Holding4.25%▼ 0.23 pp1.36%▲ 0.83 pp
Public Holding37.98%▲ 0.18 pp27.8%▼ 0.81 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KOVAI MEDICAL CENTER & HO and NOVARTIS INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.